Psoralen plus UVA protocol for compositae photosensitivity

Denise A. Burke, Gwyn Corey, Frances Storrs

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Background: Patients allergic to sesquiterpene lactones found in Compositae plants may develop severe photosensitivity, which can result in persistent light reaction. Treatment of these exquisitely photosensitive individuals can be vary difficult, often requiring hospitalization. Although some treatment regimens have used psoralen plus UVA (PUVA) therapy, no specific outpatient protocol has been established. Objective: The purpose of this study was to develop an affective PUVA outpatient regimen to treat Compositae photosensitivity. Methods: A prednisone-assisted PUVA protocol was established in which the prednisone dose was decreased weekly, and the PUVA dose was increased during the same time interval. Results: Both patients enrolled in the study experienced dramatic improvement in their previously unresponsive eruptions. Conclusions: Two men aged 66 and 80 years were subjected to this protocol. Both men had chronic photodistributed dermatitis that resolved with this treatment and in one instance has remained clear for 18 months without needing further PUVA therapy.

Original languageEnglish (US)
Pages (from-to)171-176
Number of pages6
JournalAmerican Journal of Contact Dermatitis
Volume7
Issue number3
DOIs
StatePublished - Sep 1996

Fingerprint

Ficusin
Asteraceae
Prednisone
Outpatients
Therapeutics
Sesquiterpenes
Lactones
Dermatitis
Hospitalization
Light

ASJC Scopus subject areas

  • Dermatology

Cite this

Psoralen plus UVA protocol for compositae photosensitivity. / Burke, Denise A.; Corey, Gwyn; Storrs, Frances.

In: American Journal of Contact Dermatitis, Vol. 7, No. 3, 09.1996, p. 171-176.

Research output: Contribution to journalArticle

Burke, Denise A. ; Corey, Gwyn ; Storrs, Frances. / Psoralen plus UVA protocol for compositae photosensitivity. In: American Journal of Contact Dermatitis. 1996 ; Vol. 7, No. 3. pp. 171-176.
@article{96ebc2adc291402c9a7d2043e6fd15c6,
title = "Psoralen plus UVA protocol for compositae photosensitivity",
abstract = "Background: Patients allergic to sesquiterpene lactones found in Compositae plants may develop severe photosensitivity, which can result in persistent light reaction. Treatment of these exquisitely photosensitive individuals can be vary difficult, often requiring hospitalization. Although some treatment regimens have used psoralen plus UVA (PUVA) therapy, no specific outpatient protocol has been established. Objective: The purpose of this study was to develop an affective PUVA outpatient regimen to treat Compositae photosensitivity. Methods: A prednisone-assisted PUVA protocol was established in which the prednisone dose was decreased weekly, and the PUVA dose was increased during the same time interval. Results: Both patients enrolled in the study experienced dramatic improvement in their previously unresponsive eruptions. Conclusions: Two men aged 66 and 80 years were subjected to this protocol. Both men had chronic photodistributed dermatitis that resolved with this treatment and in one instance has remained clear for 18 months without needing further PUVA therapy.",
author = "Burke, {Denise A.} and Gwyn Corey and Frances Storrs",
year = "1996",
month = "9",
doi = "10.1016/S1046-199X(96)90008-1",
language = "English (US)",
volume = "7",
pages = "171--176",
journal = "Dermatitis : contact, atopic, occupational, drug",
issn = "1710-3568",
publisher = "Decker Publishing",
number = "3",

}

TY - JOUR

T1 - Psoralen plus UVA protocol for compositae photosensitivity

AU - Burke, Denise A.

AU - Corey, Gwyn

AU - Storrs, Frances

PY - 1996/9

Y1 - 1996/9

N2 - Background: Patients allergic to sesquiterpene lactones found in Compositae plants may develop severe photosensitivity, which can result in persistent light reaction. Treatment of these exquisitely photosensitive individuals can be vary difficult, often requiring hospitalization. Although some treatment regimens have used psoralen plus UVA (PUVA) therapy, no specific outpatient protocol has been established. Objective: The purpose of this study was to develop an affective PUVA outpatient regimen to treat Compositae photosensitivity. Methods: A prednisone-assisted PUVA protocol was established in which the prednisone dose was decreased weekly, and the PUVA dose was increased during the same time interval. Results: Both patients enrolled in the study experienced dramatic improvement in their previously unresponsive eruptions. Conclusions: Two men aged 66 and 80 years were subjected to this protocol. Both men had chronic photodistributed dermatitis that resolved with this treatment and in one instance has remained clear for 18 months without needing further PUVA therapy.

AB - Background: Patients allergic to sesquiterpene lactones found in Compositae plants may develop severe photosensitivity, which can result in persistent light reaction. Treatment of these exquisitely photosensitive individuals can be vary difficult, often requiring hospitalization. Although some treatment regimens have used psoralen plus UVA (PUVA) therapy, no specific outpatient protocol has been established. Objective: The purpose of this study was to develop an affective PUVA outpatient regimen to treat Compositae photosensitivity. Methods: A prednisone-assisted PUVA protocol was established in which the prednisone dose was decreased weekly, and the PUVA dose was increased during the same time interval. Results: Both patients enrolled in the study experienced dramatic improvement in their previously unresponsive eruptions. Conclusions: Two men aged 66 and 80 years were subjected to this protocol. Both men had chronic photodistributed dermatitis that resolved with this treatment and in one instance has remained clear for 18 months without needing further PUVA therapy.

UR - http://www.scopus.com/inward/record.url?scp=0029819355&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029819355&partnerID=8YFLogxK

U2 - 10.1016/S1046-199X(96)90008-1

DO - 10.1016/S1046-199X(96)90008-1

M3 - Article

C2 - 8957334

AN - SCOPUS:0029819355

VL - 7

SP - 171

EP - 176

JO - Dermatitis : contact, atopic, occupational, drug

JF - Dermatitis : contact, atopic, occupational, drug

SN - 1710-3568

IS - 3

ER -